Aurobindo Pharma Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Mar '24
    Total Qtr Revenue cr
    8,516.93
    8,135.81
    7,932.07
    7,787.95
    7,715.77
    Other Income Qtr Cr134.81157.29136.00220.93135.62
    Operating Revenues Qtr8,382.127,978.527,796.077,567.027,580.15

    *All values are in Cr.

    Operating Expenses Qtr
    6,590.20
    6,400.54
    6,229.93
    5,947.45
    5,907.34
    Operating Profit Qtr
    1,791.92
    1,577.98
    1,566.14
    1,619.57
    1,672.81
    EBITDA Qtr Cr
    1,926.73
    1,735.27
    1,702.14
    1,840.50
    1,686.32
    Depreciation Qtr
    444.43
    418.53
    382.28
    404.18
    354.33
    Net Profit Qtr
    903.47
    845.81
    817.38
    919.22
    908.75
    Basic EPS Qtr
    15.56
    14.56
    14.00
    15.69
    15.51
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -